Early Drug Development: Rationale for an effective organization model.

At the 2014 Exploratory Clinical Development World Europe, Isabelle Paty, Head of Clinical Pharmacology/Early Drug Development, Ipsen, gave a presentation on “Early Drug Development: Rationale for an effective organization model.”

Download and learn:

  • Introduction: Ipsen as a mid- size Pharma
  • Challenges for Early Drug Development
  • Conclusion and perspectives

Download Presentation.

Found this interesting? Join us in 2015 for the 9th annual Exploratory Clinical Development World.  The conference is recognised as the premier conference for understanding the right strategies and methods to assess safety & efficacy and make timely go/no go decisions. Learn how to avoid the expense of carrying ineffective novel agents into full scale clinical development.

Find out more>

Leave a Reply

Your email address will not be published. Required fields are marked *